Atlas FDA

LIPOSORBER LA-15 System

FDA premarket approval P910018/S033 · decided 2022-04-29

Approval details

PMA number
P910018
Supplement
S033
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LIPOSORBER LA-15 System
Generic name
Lipoprotein, low density, removal
Applicant
Kaneka Pharma America Corp.
Date received
2022-03-30
Decision date
2022-04-29
Days to decision
30 days
Decision code
OK30
Product code
MMY
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
New York, NY
Statement
Qualification of new equipment for the EVOH coating process and the Hollow Fiber (HF) drying process to increase hollow fiber production capacity.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.